View in EDS HTML Full Text PDF Full Text

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.
Authors: Bauer J; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Köhler N; Department of Internal Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany.; CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany., Maringer Y; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Bucher P; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany., Bilich T; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Zwick M; Department of Internal Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany.; Faculty of Biology, Albert-Ludwigs-Universität, Freiburg, Germany., Dicks S; Faculty of Biology, Albert-Ludwigs-Universität, Freiburg, Germany.; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Nelde A; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Dubbelaar M; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany., Scheid J; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany., Wacker M; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Heitmann JS; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Schroeder S; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Department of Otorhinolaryngology, Head and Neck Surgery, University of Tübingen, Tübingen, Germany., Rieth J; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Denk M; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tübingen, Germany., Richter M; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tübingen, Germany., Klein R; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Bonzheim I; Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany., Luibrand J; Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany., Holzer U; Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany., Ebinger M; Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany., Brecht IB; Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany., Bitzer M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tübingen, Germany.; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany., Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site, Freiburg, Germany., Feucht J; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany., Salih HR; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Rammensee HG; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tübingen, Germany., Hailfinger S; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Walz JS; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.
Source: Nature communications [Nat Commun] 2022 Oct 27; Vol. 13 (1), pp. 6401. Date of Electronic Publication: 2022 Oct 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36302754
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bauer+J%22">Bauer J</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Köhler+N%22">Köhler N</searchLink>; Department of Internal Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany.; CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Maringer+Y%22">Maringer Y</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bucher+P%22">Bucher P</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bilich+T%22">Bilich T</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Zwick+M%22">Zwick M</searchLink>; Department of Internal Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany.; Faculty of Biology, Albert-Ludwigs-Universität, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Dicks+S%22">Dicks S</searchLink>; Faculty of Biology, Albert-Ludwigs-Universität, Freiburg, Germany.; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Nelde+A%22">Nelde A</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Dubbelaar+M%22">Dubbelaar M</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Scheid+J%22">Scheid J</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Wacker+M%22">Wacker M</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Heitmann+JS%22">Heitmann JS</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schroeder+S%22">Schroeder S</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Department of Otorhinolaryngology, Head and Neck Surgery, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Rieth+J%22">Rieth J</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Denk+M%22">Denk M</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Richter+M%22">Richter M</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Klein+R%22">Klein R</searchLink>; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bonzheim+I%22">Bonzheim I</searchLink>; Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Luibrand+J%22">Luibrand J</searchLink>; Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Holzer+U%22">Holzer U</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Ebinger+M%22">Ebinger M</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Brecht+IB%22">Brecht IB</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bitzer+M%22">Bitzer M</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tübingen, Germany.; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Boerries+M%22">Boerries M</searchLink>; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Feucht+J%22">Feucht J</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Pediatric Hematology and Oncology, University Children's Hospital, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Salih+HR%22">Salih HR</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Rammensee+HG%22">Rammensee HG</searchLink>; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hailfinger+S%22">Hailfinger S</searchLink>; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Walz+JS%22">Walz JS</searchLink>; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2022 Oct 27; Vol. 13 (1), pp. 6401. <i>Date of Electronic Publication: </i>2022 Oct 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36302754
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-022-33746-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6401
    Titles:
      – TitleFull: The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bauer J
      – PersonEntity:
          Name:
            NameFull: Köhler N
      – PersonEntity:
          Name:
            NameFull: Maringer Y
      – PersonEntity:
          Name:
            NameFull: Bucher P
      – PersonEntity:
          Name:
            NameFull: Bilich T
      – PersonEntity:
          Name:
            NameFull: Zwick M
      – PersonEntity:
          Name:
            NameFull: Dicks S
      – PersonEntity:
          Name:
            NameFull: Nelde A
      – PersonEntity:
          Name:
            NameFull: Dubbelaar M
      – PersonEntity:
          Name:
            NameFull: Scheid J
      – PersonEntity:
          Name:
            NameFull: Wacker M
      – PersonEntity:
          Name:
            NameFull: Heitmann JS
      – PersonEntity:
          Name:
            NameFull: Schroeder S
      – PersonEntity:
          Name:
            NameFull: Rieth J
      – PersonEntity:
          Name:
            NameFull: Denk M
      – PersonEntity:
          Name:
            NameFull: Richter M
      – PersonEntity:
          Name:
            NameFull: Klein R
      – PersonEntity:
          Name:
            NameFull: Bonzheim I
      – PersonEntity:
          Name:
            NameFull: Luibrand J
      – PersonEntity:
          Name:
            NameFull: Holzer U
      – PersonEntity:
          Name:
            NameFull: Ebinger M
      – PersonEntity:
          Name:
            NameFull: Brecht IB
      – PersonEntity:
          Name:
            NameFull: Bitzer M
      – PersonEntity:
          Name:
            NameFull: Boerries M
      – PersonEntity:
          Name:
            NameFull: Feucht J
      – PersonEntity:
          Name:
            NameFull: Salih HR
      – PersonEntity:
          Name:
            NameFull: Rammensee HG
      – PersonEntity:
          Name:
            NameFull: Hailfinger S
      – PersonEntity:
          Name:
            NameFull: Walz JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 10
              Text: 2022 Oct 27
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1